December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Dhan Chand: Honored to have presented at the Global Cancer Movement Conference
Dec 15, 2024, 11:51

Dhan Chand: Honored to have presented at the Global Cancer Movement Conference

Dhan Chand, Vice President of Research at Agenus, reshared a post on LinkedIn by OncoDaily, adding:

“Honored to have presented at the Global Cancer Movement Conference, where I discussed botensilimab and its promising potential in colorectal cancer treatment.

Special thanks to OncoDaily for sharing my presentation and making it freely accessible to all on YouTube.

Together, we’re challenging conventional thinking and working toward better outcomes for patients.”

Quoting OncoDaily’s post:

“Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers

Botensilimab is poised to revolutionize the treatment of MSS colorectal cancer, offering promising results and a new hope for patients with limited options.”

Dhan Chand, Ph.D., is Vice President of Research at Agenus, focusing on cancer immunology, immunotherapy, and cell and molecular biology. Previously, he served as a Graduate Research Assistant and Project Co-Leader in the Department of Cell and Systems Biology at the University of Toronto

Furter Reading:

Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 1

Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 2

Highlights from Global Cancer Movement: Challenging the Status Quo in Colorectal Cancer – Day 3